TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31604088

Group type: EXPERIMENTAL
Intervention: Intramuscular triamcinolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biologics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ASSESS tool
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Replication analyses
Number of subjects: 0
Study: 31102988

Group type: EXPERIMENTAL
Intervention: Type D nasopharyngeal carcinoma (NPC)
Number of subjects: 5194

Group type: COMPARATOR
Intervention: Type A nasopharyngeal carcinoma (NPC)
Number of subjects: 5194
Study: 27492149

Group type: EXPERIMENTAL
Intervention: Personalised nutrition with more frequent feedback
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Personalised nutrition with less frequent feedback
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Generalised dietary guidelines (Control)
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Participants interested in losing weight
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Participants who skip meals
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Participants who eat healthily frequently
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Participants less than 45 years old
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Obese participants
Number of subjects: 1607
Study: 25974640

Group type: EXPERIMENTAL
Intervention: LY2963016 insulin glargine
Number of subjects: 535

Group type: COMPARATOR
Intervention: Lantus® insulin glargine
Number of subjects: 535
Study: 24130072

Group type: EXPERIMENTAL
Intervention: CHOP-R (cyclophosphamide-Adriamycin-vincristine-prednisone-rituximab)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: CHOP-RIT (CHOP followed by iodine-131 tositumomab radioimmunotherapy)
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: CHOP-R
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: CHOP-RIT
Number of subjects: 532

Group type: COMPARATOR
Intervention: Both arms
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: LDH + β2M model
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Low-risk patients
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: High-risk patients
Number of subjects: 532
Study: 22108485

Group type: EXPERIMENTAL
Intervention: Formula based on oligomeric proanthocyanidins (OPA)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Formula based on bioflavonoids
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 19589522

Group type: EXPERIMENTAL
Intervention: Minimal stimulation using recombinant human FSH (rhFSH) and GnRH antagonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: GnRH antagonist multiple-dose protocol (MDP)
Number of subjects: 0
Study: 16310924

Group type: EXPERIMENTAL
Intervention: BXL628 150 mcg daily
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 15595296

Group type: EXPERIMENTAL
Intervention: 1-hour low-intensity cycling for 4 days
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 3-hour low-intensity cycling for 4 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low-intensity cycling (1 and 3 hours)
Number of subjects: 11
Study: 11084188

Group type: EXPERIMENTAL
Intervention: Cervical length measured by transvaginal ultrasound
Number of subjects: 760
Study: 9061804

Group type: EXPERIMENTAL
Intervention: Cholecystokinin tetrapeptide (CCK‐4)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 8238828

Group type: EXPERIMENTAL
Intervention: mivacurium
Number of subjects: 69

Group type: COMPARATOR
Intervention: suxamethonium
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: mivacurium and suxamethonium
Number of subjects: 69
Study: 2844338

Group type: EXPERIMENTAL
Intervention: Intravenous cytomegalovirus immune globulin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control (no intravenous cytomegalovirus immune globulin)
Number of subjects: 97
Study: 29742109

Group type: EXPERIMENTAL
Intervention: Imipramine 75 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Active placebo (tolterodine 1 mg)
Number of subjects: 50
Study: 27246708

Group type: EXPERIMENTAL
Intervention: PSS + NPWT
Number of subjects: 59

Group type: COMPARATOR
Intervention: PSS alone
Number of subjects: 59
Study: 25413975

Group type: EXPERIMENTAL
Intervention: Phototherapy (combination of super-pulsed laser and light-emitting diodes)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 13
Study: 23428336

Group type: EXPERIMENTAL
Intervention: L-Acetylcarnitine (LAC) plus placebo
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fluoxetine 20 mg/die plus placebo
Number of subjects: 80
Study: 22012905

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Stent application
Number of subjects: 88
Study: 18438230

Group type: EXPERIMENTAL
Intervention: W+B (water + 5 g x L(‐1) betaine)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: C+B (6% carbohydrate-electrolyte fluid + 5 g x L(‐1) betaine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: C (6% carbohydrate-electrolyte fluid)
Number of subjects: 10

Group type: COMPARATOR
Intervention: W (flavored, non-caloric water)
Number of subjects: 10
Study: 16937274

Group type: EXPERIMENTAL
Intervention: Once-weekly 17.5 mg risedronate
Number of subjects: 496

Group type: COMPARATOR
Intervention: Once-daily 2.5 mg risedronate
Number of subjects: 496
Study: 12876107

Group type: EXPERIMENTAL
Intervention: Guidelines for Assessing Postnatal Problems (GAPP) educational programme
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: GAPP educational programme
Number of subjects: 68
Study: 11128859

Group type: EXPERIMENTAL
Intervention: 38 mg x kg(‐1) x d(‐1) of HMB
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 76 mg x kg(‐1) x d(‐1) of HMB
Number of subjects: 37

Group type: COMPARATOR
Intervention: 0 mg x kg(‐1) x d(‐1) (Control)
Number of subjects: 37
Study: 9083616

Group type: EXPERIMENTAL
Intervention: HECCM from viable pregnancies (n=11)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HECCM from non-viable pregnancies (n=25)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control media (n=17)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All samples analyzed for IL-6
Number of subjects: 36
Study: 8077790

Group type: EXPERIMENTAL
Intervention: Hypervolemic hemodilution without venesection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypervolemic hemodilution with venesection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (well hydrated with cristalloid saline solution)
Number of subjects: 0
Study: 2808984

Group type: EXPERIMENTAL
Intervention: Rate-modulating minute ventilation VVIR pacing mode
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fixed-rate VVI pacing mode
Number of subjects: 10
Study: 795379

Group type: EXPERIMENTAL
Intervention: Fluocinonide gel
Number of subjects: 335

Group type: COMPARATOR
Intervention: Betamethasone benzoate gel
Number of subjects: 335
Study: 31238919

Group type: EXPERIMENTAL
Intervention: Guideline + Capacity Building Intervention (GL + CBI)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Guideline only (GL-ONLY)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No guidelines (NO-GL)
Number of subjects: 49
Study: 29149146

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg with bupivacaine 0.25%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 ug/kg with bupivacaine 0.25%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine 0.25% alone (Control group)
Number of subjects: 60
Study: 26711672

Group type: EXPERIMENTAL
Intervention: Maternal kissing
Number of subjects: 943

Group type: COMPARATOR
Intervention: Sham kissing
Number of subjects: 943

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 943
Study: 25142189

Group type: EXPERIMENTAL
Intervention: Palifermin (60 μg/kg IV for 3 days before and after chemotherapy)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Palifermin
Number of subjects: 155
Study: 23031471

Group type: EXPERIMENTAL
Intervention: Indoors feeding system with 21-day regrowth of Digitaria decumbens grass
Number of subjects: 20

Group type: COMPARATOR
Intervention: At pasture feeding system with 21-day regrowth of Digitaria decumbens grass
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indoors feeding system with 35-day regrowth of Digitaria decumbens grass
Number of subjects: 20

Group type: COMPARATOR
Intervention: At pasture feeding system with 35-day regrowth of Digitaria decumbens grass
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indoors feeding system
Number of subjects: 20

Group type: COMPARATOR
Intervention: At pasture feeding system
Number of subjects: 20
Study: 19614803

Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg) + Aspirin (300 mg/d)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 17599726

Group type: EXPERIMENTAL
Intervention: Infliximab plus methotrexate (MTX)
Number of subjects: 120
Study: 16283848

Group type: EXPERIMENTAL
Intervention: Modified dry suture
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard dry suture
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Modified wet suture
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard wet suture
Number of subjects: 14
Study: 12100662

Group type: EXPERIMENTAL
Intervention: Emotion-orientated care (EOC) training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control homes (no specific intervention)
Number of subjects: 16
Study: 9660521

Group type: EXPERIMENTAL
Intervention: Barnidipine (10 mg) once daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nitrendipine (10 mg) once daily
Number of subjects: 24
Study: 8533908

Group type: EXPERIMENTAL
Intervention: 1-day stored platelets
Number of subjects: 25

Group type: COMPARATOR
Intervention: 4-day stored platelets
Number of subjects: 25
Study: 2039655

Group type: EXPERIMENTAL
Intervention: 400 mg Aminophylline
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 6945041

Group type: EXPERIMENTAL
Intervention: Diet A (low cholesterol)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Diet B (low cholesterol, high polyunsaturated fat)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Diet C (low cholesterol, very low fat)
Number of subjects: 62
Study: 31924736

Group type: EXPERIMENTAL
Intervention: RT/TMZ + Bevacizumab (BEV), n = 59
Number of subjects: 113

Group type: COMPARATOR
Intervention: RT/TMZ, n = 54
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: RT/TMZ + Bevacizumab (BEV) and RT/TMZ
Number of subjects: 113
Study: 30124941

Group type: EXPERIMENTAL
Intervention: LESU200+XOI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LESU400+XOI
Number of subjects: 0

Group type: COMPARATOR
Intervention: XOI
Number of subjects: 0
Study: 29658236

Group type: EXPERIMENTAL
Intervention: sildenafil citrate (SC, n = 111)
Number of subjects: 222

Group type: COMPARATOR
Intervention: placebo (n = 111)
Number of subjects: 222
Study: 25999045

Group type: EXPERIMENTAL
Intervention: Exposure to obesity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular exposure to heavier body weights
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to obesity in an online dating context
Number of subjects: 0
Study: 23228813

Group type: EXPERIMENTAL
Intervention: Quadrivalent inactivated influenza vaccine (QIV)
Number of subjects: 190

Group type: COMPARATOR
Intervention: 2009‐2010 TIV
Number of subjects: 190

Group type: COMPARATOR
Intervention: 2008‐2009 TIV
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: All groups (QIV, 2009‐2010 TIV, 2008‐2009 TIV)
Number of subjects: 190
Study: 22097175

Group type: EXPERIMENTAL
Intervention: Prednisone treatment after regression of proteinuria (Group B)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Proteinuria (Group A)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (20 children, aged 8.5 ± 3.6 years)
Number of subjects: 18
Study: 19485628

Group type: EXPERIMENTAL
Intervention: Integrative Data Analysis (IDA)
Number of subjects: 0
Study: 16982486

Group type: EXPERIMENTAL
Intervention: Zinc sulphate (15 mg of zinc) once daily for prophylaxis, increased to 30 mg at onset of cold
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 15125032

Group type: EXPERIMENTAL
Intervention: Cycle ergometry exercise 3 times per week during dialysis at 40-50% maximal work capacity for 15 min during the first 3 hours of dialysis (EX)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cycle ergometry exercise (EX)
Number of subjects: 13
Study: 10649149

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol plus norethindrone acetate (50 microg/d estradiol + 140/250/400 microg/d norethindrone acetate)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 1341607

Group type: EXPERIMENTAL
Intervention: Pulsatile insulin delivery (1.0 mU/kg x min in 2 minute pulses every 13 minutes)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Continuous insulin delivery (0.15 mU/kg x min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Continuous insulin delivery (0.20 mU/kg x min)
Number of subjects: 7
Study: 6130244

Group type: EXPERIMENTAL
Intervention: More intensive management program (group A) using ultralente insulin as basal cover and soluble insulin at mealtimes, with more frequent clinic visits, closer dietary supervision, and home blood glucose monitoring
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual diabetic care (group U)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: More intensive management program (group A)
Number of subjects: 74
Study: 30600270

Group type: EXPERIMENTAL
Intervention: Genomic sequencing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Return of genomic results for adult-onset conditions
Number of subjects: 0
Study: 30859782

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 454

Group type: COMPARATOR
Intervention: Physical Inactivity
Number of subjects: 454

Group type: COMPARATOR
Intervention: Overweight/Obesity
Number of subjects: 454
Study: 26927207

Group type: EXPERIMENTAL
Intervention: 12-mm diameter fully covered self-expandable metallic stent (FCSEMS)
Number of subjects: 38
Study: 23175678

Group type: EXPERIMENTAL
Intervention: In-group representation (red or blue team)
Number of subjects: 0
Study: 23204157

Group type: EXPERIMENTAL
Intervention: Prem-8 (n = 38)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control formula (n = 33)
Number of subjects: 71
Study: 20492040

Group type: EXPERIMENTAL
Intervention: Education plus Tai Chi Chuan
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Any of the three interventions (Education, Tai Chi Chuan, Education plus Tai Chi Chuan)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 163
Study: 18555160

Group type: EXPERIMENTAL
Intervention: Dutch fall prevention program (adapted from a British program)
Number of subjects: 21
Study: 16000604

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (PORT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant systemic chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modern radiotherapy techniques
Number of subjects: 0
Study: 12850128

Group type: EXPERIMENTAL
Intervention: Salmeterol & Fluticasone (SM&FP) 50/250 microg bid
Number of subjects: 18
Study: 10401443

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 4
Study: 8914312

Group type: EXPERIMENTAL
Intervention: Sensation Level (SL) at sound frequencies of 0.125, 0.5, 1, 2, 4, 6, and 8 kHz with levels set at 10, 20, 40, 60, and 80 dB.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loudness Level (LL) corresponding to SL at 1 kHz.
Number of subjects: 0
Study: 1771386

Group type: EXPERIMENTAL
Intervention: Magaldrate (800 mg every 4 h)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 6745010

Group type: EXPERIMENTAL
Intervention: 10% lapyrium chloride (LC)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 15% lapyrium chloride (LC)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 20% lapyrium chloride (LC)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.3% sodium lauryl sulfate (SLS)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.5% sodium lauryl sulfate (SLS)
Number of subjects: 22
Study: 31049566

Group type: EXPERIMENTAL
Intervention: High-Carbohydrate Meal (HC, carbohydrates: 89% of energy)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Normo-Carbohydrate Meal (NC, carbohydrates: 45% of energy)
Number of subjects: 21
Study: 29500454

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan (400 mg QD)
Number of subjects: 70

Group type: COMPARATOR
Intervention: amlodipine (10 mg QD)
Number of subjects: 70
Study: 26305394

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: General Psychiatric Management (GPM)
Number of subjects: 180

Group type: COMPARATOR
Intervention: BPD patients with comorbid PTSD
Number of subjects: 180

Group type: COMPARATOR
Intervention: BPD patients without PTSD
Number of subjects: 180

Group type: COMPARATOR
Intervention: Both groups (with and without PTSD)
Number of subjects: 180
Study: 24777959

Group type: EXPERIMENTAL
Intervention: Topical menthol application
Number of subjects: 10
Study: 23805175

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combination training (ATRT)
Number of subjects: 35
Study: 21386723

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control Group (no stretching)
Number of subjects: 45
Study: 18580879

Group type: EXPERIMENTAL
Intervention: Domperidone (0.3 mg/kg per os at the eighth and sixteenth hour)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 16533619

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 12660520

Group type: EXPERIMENTAL
Intervention: HLAMatchmaker algorithm for identifying compatible donors
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: HLAMatchmaker algorithm with additional antigens
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: HLAMatchmaker algorithm considering one-triplet mismatches
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: HLAMatchmaker algorithm considering two-triplet mismatches
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: HLAMatchmaker algorithm with acceptable antigens identified by serum screens
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: HLAMatchmaker algorithm with additional acceptable antigens
Number of subjects: 54
Study: 10993856

Group type: EXPERIMENTAL
Intervention: Biatrial pacing at a base rate of 80 bpm
Number of subjects: 130

Group type: COMPARATOR
Intervention: No pacing (control group, base rate 30 bpm)
Number of subjects: 130
Study: 8707471

Group type: EXPERIMENTAL
Intervention: Treatment group (stressed students with LD)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (nonstressed students with LD)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Treatment group (regular education students)
Number of subjects: 45
Study: 1848385

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Logiparin) 50 IU anti-Xa per kilo body weight once daily
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo (saline injection)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (Logiparin)
Number of subjects: 190
Study: 6860529

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Labetalol (300 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31471834

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) therapy for more than 6 months
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) therapy for 6-12 months
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) therapy for 12-18 months
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) therapy for >24 months
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) therapy
Number of subjects: 503
Study: 30383589

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 2629

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2629
Study: 27965485

Group type: EXPERIMENTAL
Intervention: 20 mL of 2 to 4°C cold saline irrigated during 5 minutes using EndoVac
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 20 mL of room temperature saline irrigated during 5 minutes using EndoVac
Number of subjects: 75

Group type: COMPARATOR
Intervention: No additional irrigation applied (control)
Number of subjects: 75
Study: 25214768

Group type: EXPERIMENTAL
Intervention: Test drug (300 mg gabapentin)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Reference drug (300 mg gabapentin)
Number of subjects: 37
Study: 22246113

Group type: EXPERIMENTAL
Intervention: Glass fiber post (GFP) with 10 mm post space
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Glass fiber post (GFP) with 5 mm post space
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ribbond fiber post (RFP) with 5 mm post space
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ribbond fiber post (RFP) with 10 mm post space
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no post placed)
Number of subjects: 75
Study: 20568096

Group type: EXPERIMENTAL
Intervention: MitoQ
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 17389704

Group type: EXPERIMENTAL
Intervention: MMI 30 mg/d
Number of subjects: 240

Group type: COMPARATOR
Intervention: PTU 300 mg/d
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: MMI 15 mg/d
Number of subjects: 240